Toyota Enters Space Race with Rocket Investment

  • 📰 nbcchicago
  • ⏱ Reading Time:
  • 43 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 37%
  • Publisher: 51%

Business News

Space Exploration,Toyota,Rocket Development

Toyota Motor is investing in Interstellar Technologies, a Japanese startup developing orbital launch vehicles, marking the automaker's foray into the space industry. Toyota Chairman Akio Toyoda stated that the company believes the future of mobility extends beyond Earth and aims to leverage its mass production expertise for rocket development.

Toyota Motor is exploring the development and production of orbital rockets, Chairman Akio Toyoda said Monday.

"We are exploring rockets too, because the future of mobility shouldn't be limited to just earth or just one car company, for that matter," Toyoda said during a press conference for CES.The automaker, through its"Woven by Toyota" mobility company, is investing 7 billion Japanese yen into Interstellar Technologies Inc., a Japanese private spaceflight company developing launch vehicles for satellites.

In the Japanese launch market, Toyota is taking on Mitsubishi, whose subsidiary Mitsubishi Heavy Industries has developed and launched the H3 series of rockets for JAXA, the country's space agency. Mitsubishi's H3 rocket, which debuted several years behind schedule, was intended to be priced competitively with SpaceX's Falcon 9 rockets, which dominate the current global launch market.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 545. in CA
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stock Market Drops After Fed Rate Cut, Merck Enters Obesity Drug RaceThe Federal Reserve cut interest rates by 25 basis points but the market reacted negatively. Merck made a $2 billion deal for an experimental obesity drug.
Source: CNBC - 🏆 12. / 72 Read more »